Pharis Mohideen - Nov 20, 2023 Form 4 Insider Report for DBV Technologies S.A. (DBVT)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
DBVT
Transactions as of
Nov 20, 2023
Transactions value $
$0
Form type
4
Date filed
11/22/2023, 07:03 AM
Previous filing
Aug 14, 2023
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBVT Ordinary Shares Award $0 +35K +70.79% $0.00 84.4K Nov 20, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBVT Employee Stock Option (right to buy) Award $0 +215K $0.00 215K Nov 20, 2023 Ordinary Shares 215K $2.19 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 20, 2024, subject to the Reporting Person continuing to provide service through each such date.
F2 This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0928 to EURO 1.00 as of November 20, 2023.
F3 The option shall vest in four equal annual installments commencing on November 20, 2024, subject to the Reporting Person continuing to provide service through each such date.